Reshma Kewalramani (Vertex via YouTube)
January 11, 2021 11:30 AM ESTUpdated 12:11 PM
Deals

#JPM21: Resh­ma Ke­wal­ra­mani is on the hunt for 'mid-to late-stage as­sets,' new tools to re­plen­ish Ver­tex pipeline

Amber Tong

It’s her first JP Mor­gan as CEO of Ver­tex, and Resh­ma Ke­wal­ra­mani is hit­ting the ground run­ning.

The part­ner­ships she in­her­it­ed from pre­de­ces­sor Jeff Lei­den …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times